Forte Biosciences, Inc.
Biotechnology · Healthcare
CFO
2020-06-15–present
Antony Riley
CFO
Forte Biosciences, Inc.
Equibles does not estimate personal net worth.
About Antony Riley
Antony Riley is recorded as CFO at Forte Biosciences, Inc. since June 15, 2020. The proxy statement of Forte Biosciences, Inc. reports total compensation of $856,875 for Antony Riley in fiscal 2024, including a base salary of $434,730. Disclosed compensation is on record for 6 fiscal years. Forte Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector.
Affiliation history
-
Forte Biosciences, Inc.
CFO
SEC 8-K
Current2020-06-15–present
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Forte Biosciences, Inc. | Chief Financial Officer | $434,730 | $856,875 |
| 2023 | Forte Biosciences, Inc. | Chief Financial Officer | $418,000 | $722,980 |
| 2022 | Forte Biosciences, Inc. | Chief Financial Officer | $380,000 | $610,278 |
| 2021 | Forte Biosciences, Inc. | Chief Financial Officer | $380,000 | $1,766,784 |
| 2020 | Forte Biosciences, Inc. | Chief Financial Officer | $264,075 | $1,056,250 |
| 2019 | Forte Biosciences, Inc. | Chief Financial Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.